MYR 0.61
(0.83%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 43.78 Million MYR | 5.92% |
2022 | 84.37 Million MYR | 21.53% |
2021 | 69.42 Million MYR | 51.15% |
2020 | 45.93 Million MYR | 75.21% |
2019 | 26.21 Million MYR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 22.42 Million MYR | -11.28% |
2024 Q2 | 25.24 Million MYR | -39.09% |
2023 Q3 | 21.78 Million MYR | -0.19% |
2023 FY | 89.36 Million MYR | 5.92% |
2023 Q2 | 21.82 Million MYR | 6.58% |
2023 Q1 | 20.48 Million MYR | 91.38% |
2023 Q4 | 25.27 Million MYR | 15.99% |
2022 Q3 | 11.98 Million MYR | 0.0% |
2022 FY | 84.37 Million MYR | 21.53% |
2022 Q4 | 10.7 Million MYR | -10.7% |
2021 FY | 69.42 Million MYR | 51.15% |
2020 FY | 45.93 Million MYR | 75.21% |
2019 FY | 26.21 Million MYR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Artroniq Berhad | 9.5 Million MYR | -360.427% |
QES Group Berhad | 60.91 Million MYR | 28.13% |
Pharmaniaga Berhad | 307.82 Million MYR | 85.777% |
Apex Healthcare Berhad | 214.82 Million MYR | 79.62% |